Conference Details - Agenda

View all Conferences

Continuing Education Information

Physicians: Physicians’ Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource designates this educational activity for a maximum of 18 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA category 1 CME credit for the PRA from organizations accredited by the ACCME.

Registered Nurses: The California Board of Registered Nursing accepts AMA PRA Category 1 Credits ™ toward license renewal. On the BRN license renewal form, report the number of hours you attended (up to 18 hours of credit) and fill in “CME Category 1” for the provider number.

California AB 1195: This activity complies with California Assembly Bill 1195, signed November 2005, requiring continuing medical education courses with patient care components to include curricula in the subject of cultural and linguistic competency. The planners, speakers and authors of this CME activity have been encouraged to address issues relevant in their topic area.

Ninth International Congress on the Future of Breast Cancer

Estancia La Jolla Hotel
La Jolla, CA
July 22-25, 2010

Thursday, July 22, 2010

12:00 pm Registration
12:30 pm Welcome and Introductions
12:40 pm Keynote: Breast Cancer Steroid Receptor Targets
Ronald M. Evans
1:05 pm Presession Survey
Best of Breast Cancer Science: Breast Cancer–Initiating Cells
1:15 pm Breast Cancer Heterogeneity and Metastases
Joseph R. Nevins
1:40 pm Tracking and Targeting Breast Cancer–Initiating Cells
Jeffrey M. Rosen
2:05 pm Best of Breast Cancer Clinical Science: Highlights From 2009
Kathy Albain
2:35 pm Panel Discussion
2:55 pm Break
Hormone Receptor–Driven Breast Cancer
3:15 pm Classification of Hormone Receptor–Positive Breast Cancer
Sunil Badve
3:35 pm New Insights Into Optimizing Endocrine Therapy: Adjuvant
Stephen E. Jones
3:55 pm New Insights Into Optimizing Endocrine Therapy: Metastatic
Stefan Glück
4:15 pm Optimizing Premenopausal Adjuvant Endocrine Therapy: The First 5 Years
Jo Anne Zujewski
4:35 pm Optimizing Premenopausal Adjuvant Endocrine Therapy: Endocrine Therapy for Life?
Frankie Ann Holmes
4:55 pm Overcoming Endocrine Therapy Resistance: Views of a Basic Scientist
Suzanne A. W. Fuqua
5:15 pm Overcoming Endocrine Therapy Resistance: Views of a Clinical Scientist
Douglas Yee
5:35 pm Postsession Survey
5:45 pm Panel Discussion
6:05 pm Adjourn
7:00 pm-9:00 pm Welcome Reception

Educational Grants

An educational grant for this activity was provided by:


  1. Genentech BioOncology
  2. Lilly USA, LLC
  3. Bristol-Myers Squibb
  4. Novartis Oncology
  5. sanofi-aventis U.S.
  6. Abraxis BioScience
  7. AstraZeneca
  8. GTx, Inc.